OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Benefits and pitfalls: Epigenetic modulators in prostate cancer intervention
Neha Upadhyay, Kalpana Tilekar, Jessica D. Hess, et al.
Current Research in Chemical Biology (2021) Vol. 1, pp. 100006-100006
Open Access | Times Cited: 7
Neha Upadhyay, Kalpana Tilekar, Jessica D. Hess, et al.
Current Research in Chemical Biology (2021) Vol. 1, pp. 100006-100006
Open Access | Times Cited: 7
Showing 7 citing articles:
From pituitary cells to prostate gland in health and disease: direct and indirect endocrine connections
André Sarmento‐Cabral, Antonio C. Fuentes-Fayos, Fernando Mata Ordóñez, et al.
Reviews in Endocrine and Metabolic Disorders (2025)
Open Access
André Sarmento‐Cabral, Antonio C. Fuentes-Fayos, Fernando Mata Ordóñez, et al.
Reviews in Endocrine and Metabolic Disorders (2025)
Open Access
Molecular heterogeneity in prostate cancer and the role of targeted therapy
Sabiha M. Khan, Prakash Baligar, Chanderdeep Tandon, et al.
Life Sciences (2023) Vol. 336, pp. 122270-122270
Closed Access | Times Cited: 8
Sabiha M. Khan, Prakash Baligar, Chanderdeep Tandon, et al.
Life Sciences (2023) Vol. 336, pp. 122270-122270
Closed Access | Times Cited: 8
Targeting Protein Kinases and Epigenetic Control as Combinatorial Therapy Options for Advanced Prostate Cancer Treatment
Soghra Bagheri, Mahdie Rahban, Fatemeh Bostanian, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 515-515
Open Access | Times Cited: 12
Soghra Bagheri, Mahdie Rahban, Fatemeh Bostanian, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 515-515
Open Access | Times Cited: 12
Epigenetics as a Key Factor in Prostate Cancer
Kadriia Enikeeva, Guzel Rafikova, Yuliya Sharifyanova, et al.
Advanced Biology (2024) Vol. 8, Iss. 5
Closed Access | Times Cited: 2
Kadriia Enikeeva, Guzel Rafikova, Yuliya Sharifyanova, et al.
Advanced Biology (2024) Vol. 8, Iss. 5
Closed Access | Times Cited: 2
Exploring the role of pomalidomide in androgen-dependent prostate cancer: a computational analysis
Shivani Pathak, Vipendra Kumar Singh, Prashant Kumar Gupta, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 2
Shivani Pathak, Vipendra Kumar Singh, Prashant Kumar Gupta, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 2
H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets
Liliana Burlibaşa, Alina-Teodora Nicu, Mariana Carmen Chifiriuc, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
Liliana Burlibaşa, Alina-Teodora Nicu, Mariana Carmen Chifiriuc, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
Multifunctional nanocarrier-mediated codelivery for targeting and treatment of prostate cancer
Ankaj Kumar, Sumedh Bahadure, Sudarshan Naidu Chilamakuri, et al.
Elsevier eBooks (2024), pp. 81-111
Closed Access | Times Cited: 1
Ankaj Kumar, Sumedh Bahadure, Sudarshan Naidu Chilamakuri, et al.
Elsevier eBooks (2024), pp. 81-111
Closed Access | Times Cited: 1
